Chronic Myeloid Leukemia: Reversing the Chronic Phase

被引：6

作者：

Goldman, John M. ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, London, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 03期

关键词：

PATIENTS RECEIVING IMATINIB; KINASE INHIBITOR; FOLLOW-UP; DASATINIB; THERAPY; NILOTINIB; RESPONSES; FAILURE;

D O I：

10.1200/JCO.2009.26.5587

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：363 / 365

页数：4

共 20 条

[1]

[Anonymous], CLIN PRACT GUID ONC

[2] Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet [J].

Baccarani, Michele ;

Saglio, Giuseppe ;

Goldman, John ;

Hochhaus, Andreas ;

Simonsson, Bengt ;

Appelbaum, Frederick ;

Apperley, Jane ;

Cervantes, Francisco ;

Cortes, Jorge ;

Deininger, Michael ;

Gratwohl, Alois ;

Guilhot, Frangois ;

Horowitz, Mary ;

Hughes, Timothy ;

Kantarjian, Hagop ;

Larson, Richard ;

Niederwieser, Dielger ;

Silver, Richard ;

Hehlmann, Rudiger .

BLOOD, 2006, 108 (06) :1809-1820

[3] Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet [J].

Baccarani, Michele ;

Cortes, Jorge ;

Pane, Fabrizio ;

Niederwieser, Dietger ;

Saglio, Giuseppe ;

Apperley, Jane ;

Cervantes, Francisco ;

Deininger, Michael ;

Gratwohl, Alois ;

Guilhot, Francois ;

Hochhaus, Andreas ;

Horowitz, Mary ;

Hughes, Timothy ;

Kantarjian, Hagop ;

Larson, Richard ;

Radich, Jerald ;

Simonsson, Bengt ;

Silver, Richard T. ;

Goldman, John ;

Hehlmann, Rudiger .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) :6041-6051

[4] Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase [J].

Cortes, Jorge E. ;

Jones, Dan ;

O'Brien, Susan ;

Jabbour, Elias ;

Konopleva, Marina ;

Ferrajoli, Alessandra ;

Kadia, Tapan ;

Borthakur, Gautam ;

Stigliano, Denise ;

Shan, Jianqin ;

Kantarjian, Hagop .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) :392-397

[5] Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia [J].

Cortes, Jorge E. ;

Jones, Dan ;

O'Brien, Susan ;

Jabbour, Elias ;

Ravandi, Farhad ;

Koller, Charles ;

Borthakur, Gautam ;

Walker, Brenda ;

Zhao, Weiqiang ;

Shan, Jianqin ;

Kantarjian, Hagop .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) :398-404

[6] International standardisation of quantitative real-time RT-PCR for BCR-ABL [J].

Cross, Nicholas C. P. ;

Hughes, Timothy P. ;

Hochhaus, Andreas ;

Goldman, John M. .

LEUKEMIA RESEARCH, 2008, 32 (03) :505-506

[7] Imatinib for newly diagnosed patients with chronic myeloid leukemia: Incidence of sustained responses in an intention-to-treat analysis [J].

de Lavallade, Hugues ;

Apperley, Jane F. ;

Khorashad, Jamshid S. ;

Milojkovic, Dragana ;

Reid, Alistair G. ;

Bua, Marco ;

Szydlo, Richard ;

Olavarria, Eduardo ;

Kaeda, Jaspal ;

Goldman, John M. ;

Marin, David .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) :3358-3363

[8]

Deininger M., 2009, Blood

[9] Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia [J].

Druker, BJ ;

Lydon, NB .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :3-7

[10] Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia [J].

Druker, Brian J. ;

Guilhot, Francois ;

O'Brien, Stephen G. ;

Gathmann, Insa ;

Kantarjian, Hagop ;

Gattermann, Norbert ;

Deininger, Michael W. N. ;

Silver, Richard T. ;

Goldman, John M. ;

Stone, Richard M. ;

Cervantes, Francisco ;

Hochhaus, Andreas ;

Powell, Bayard L. ;

Gabrilove, Janice L. ;

Rousselot, Philippe ;

Reiffers, Josy ;

Cornelissen, Jan J. ;

Hughes, Timothy ;

Agis, Hermine ;

Fischer, Thomas ;

Verhoef, Gregor ;

Shepherd, John ;

Saglio, Giuseppe ;

Gratwohl, Alois ;

Nielsen, Johan L. ;

Radich, Jerald P. ;

Simonsson, Bengt ;

Taylor, Kerry ;

Baccarani, Michele ;

So, Charlene ;

Letvak, Laurie ;

Larson, Richard A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2408-2417

← 1 2 →